Delivery Order SPE2DE24D0013-SPE2D625F0VFP
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, has been awarded a delivery order valued at $1,605.00 under contract GXMRSA-NXG-10, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is funded by the Defense Medical Supply Chain, a defense-focused federal agency. The award represents Cepheid's continued provision of molecular diagnostic technologies and services to the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0VFPDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from one of Cepheid's existing indefinite delivery vehicle contracts, specifically the Veterans Integrated Service Network 21 IDV valued at $2.5M, which focuses on polymerase chain reaction testing for laboratory microbiology including COVID-19, influenza, and respiratory syncytial virus diagnostics. Cepheid's award reflects its established position as a primary supplier of molecular diagnostic testing systems and reagents to federal healthcare agencies, particularly the Department of Veterans Affairs. The company's expertise in developing and delivering GeneXpert diagnostic systems and associated test kits for infectious disease detection aligns with the Defense Department's Medical Supply Chain procurement needs. This delivery order falls within the scope of Cepheid's broader contract portfolio with federal agencies, which includes multiple vehicle contracts exceeding $35M in aggregate value and demonstrates the company's consistent capability to support federal diagnostic and laboratory testing requirements across various healthcare systems and defense-related medical supply initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/12/25 |